Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Tau in the pancreas: understanding the link between type 2 diabetes mellitus and Alzheimer’s disease ; volume:8 ; number:1 ; day:6 ; month:12 ; year:2023 ; pages:1-2 ; date:12.2023
Signal transduction and targeted therapy ; 8, Heft 1 (6.12.2023), 1-2, 12.2023
- Klassifikation
-
Medizin, Gesundheit
- Urheber
-
Li, Wenlu
Tiedt, Steffen
Lo, Eng H.
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41392-023-01701-3
- URN
-
urn:nbn:de:101:1-2024022214124215008013
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Li, Wenlu
- Tiedt, Steffen
- Lo, Eng H.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
APOE effects on regional tau in preclinical Alzheimer’s disease
Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
APOE effects on regional tau in preclinical Alzheimer’s disease
Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum
Association between polygenic risk score of Alzheimer’s disease and plasma phosphorylated tau in individuals from the Alzheimer’s Disease Neuroimaging Initiative
Tau Biology and Tau-Directed Therapies for Alzheimer’s Disease
Tau-related grey matter network breakdown across the Alzheimer’s disease continuum
The role of pathological tau in synaptic dysfunction in Alzheimer’s diseases
Two-Year Prognostic Utility of Plasma p217+tau across the Alzheimer’s Continuum
Advances in the Pathogenesis of Alzheimer’s Disease: Focusing on Tau-Mediated Neurodegeneration
Tau-focused therapy and tau transmission: Implications for Alzheimer’s Disease and related tauopathies
Plasma N-terminal containing tau fragments (NTA-tau): a biomarker of tau deposition in Alzheimer’s Disease
The influence of APOE ε4 on the pTau interactome in sporadic Alzheimer’s disease
APOE effects on regional tau in preclinical Alzheimer’s disease
Regional cerebral tau predicts decline in everyday functioning across the Alzheimer’s disease spectrum
Antibody-free measurement of cerebrospinal fluid tau phosphorylation across the Alzheimer’s disease continuum